MONROVIA, Calif., Jun 2, 2004 /PRNewswire-FirstCall via COMTEX/ -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it has been invited to present at the Pacific Growth Equities Life Sciences Growth Conference at the Mark Hopkins Inter-Continental Hotel in San Francisco, California on Wednesday, June 9th. The Company is scheduled to discuss its business strategy and historical financial performance at 2:00 p.m. Pacific Time.

Attendance at the conference is by invitation only. STAAR Surgical will offer a live audio-only webcast of its presentation which may be accessed at STAAR's website at www.staar.com. An archived replay of the presentation will also be available immediately following at the company's website.

About STAAR Surgical

STAAR Surgical is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR's products are used by ophthalmic surgeons and include the revolutionary VISIAN ICL(TM) as well as innovative products designed to improve patient outcomes for cataracts and glaucoma. STAAR's ICL has received CE Marking, is approved for sale in 37 countries and has been implanted in more than 35,000 eyes worldwide.

CONTACT: investors, Douglas Sherk, +1-415-896-6820, or Jennifer Beugelmans, +1-415-896-6820, or media, Sheryl Seapy, +1-415-272-3323, all of EVC Group, for STAAR Surgical.

SOURCE STAAR Surgical Company

investors, Douglas Sherk, +1-415-896-6820, or
Jennifer Beugelmans, +1-415-896-6820, or media, Sheryl Seapy, +1-415-272-3323,
all of EVC Group, for STAAR Surgical Company

http://www.staar.com